Halozyme Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Halozyme Therapeutics by Rhumbline Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2013-03-31 | $565k | 98k | 5.77 |
2012-12-31 | $722k | 108k | 6.71 |
2012-09-30 | $824k | 109k | 7.56 |
2012-06-30 | $872k | 99k | 8.86 |
2012-03-31 | $1.1M | 90k | 12.76 |
2011-12-31 | $834k | 88k | 9.51 |
2011-09-30 | $721k | 117k | 6.14 |
2011-06-30 | $806k | 117k | 6.91 |
2011-03-31 | $780k | 116k | 6.71 |
2010-12-31 | $865k | 109k | 7.92 |
2010-09-30 | $783k | 102k | 7.71 |
2010-06-30 | $883k | 125k | 7.04 |
2010-03-31 | $846k | 106k | 7.99 |
2009-12-31 | $533k | 91k | 5.87 |
2009-09-30 | $646k | 91k | 7.11 |
2009-06-30 | $625k | 90k | 6.97 |
2009-03-31 | $452k | 83k | 5.45 |
2008-12-31 | $401k | 72k | 5.60 |
2008-09-30 | $419k | 57k | 7.34 |
2008-06-30 | $307k | 57k | 5.38 |
2008-03-31 | $379k | 60k | 6.36 |
2007-12-31 | $426k | 60k | 7.11 |
2007-09-30 | $489k | 56k | 8.68 |
2007-06-30 | $520k | 56k | 9.23 |